Cargando…

Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients

BACKGROUND AND AIMS: Liraglutide treatment can improve glycemic control with a concomitant weight loss, but the underlying mechanism on weight loss is not completely understood. Cardiac natriuretic peptides (NPs) can resist body fat accumulation through increasing adipocytes lypolysis. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chun-Jun, Yu, Qian, Yu, Pei, Yu, Tie-Lian, Zhang, Qiu-Mei, Lu, Shan, Yu, De-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923001/ https://www.ncbi.nlm.nih.gov/pubmed/24498905 http://dx.doi.org/10.1186/1475-2840-13-36

Ejemplares similares

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
por: Li, Chun-jun, et al.
Publicado: (2012)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
por: Okada, Kenta, et al.
Publicado: (2014)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity
por: Kistorp, Caroline, et al.
Publicado: (2014)

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
por: Fujishima, Yuya, et al.
Publicado: (2012)

Hyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution
por: Nakatsuji, Hideaki, et al.
Publicado: (2012)

Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker
por: Nunes, Sara, et al.
Publicado: (2013)

Cardiac Natriuretic Peptides: Contributors to Cardiac Cachexia or Possible Anti-obesity Agents or Both?
por: Costello-Boerrigter, Lisa C.
Publicado: (2012)

β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice
por: Tauscher, Sabine, et al.
Publicado: (2018)

The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study
por: Huang, Fang-Yang, et al.
Publicado: (2016)

Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction
por: Yagi, Kunimasa, et al.
Publicado: (2021)

Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation
por: Li, Feng, et al.
Publicado: (2023)

Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis
por: WANG, JIFENG, et al.
Publicado: (2016)

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
por: Bizino, Maurice B., et al.
Publicado: (2019)

INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist
por: Ramos, Hugo R, et al.
Publicado: (2015)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet
por: Sukumaran, Vijayakumar, et al.
Publicado: (2020)

Metabonomics Analysis of Myocardial Metabolic Dysfunction in Patients with Cardiac Natriuretic Peptide Resistance
por: Chang, Pan, et al.
Publicado: (2020)

Is Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPR-A) Expression in Human Placenta and Decidua Normal?
por: Tan, Hongchuan, et al.
Publicado: (2019)

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2015)

Hormone therapy with tamoxifen reduces plasma levels of NT-B-type natriuretic peptide but does not change ventricular ejection fraction after chemotherapy in women with breast cancer
por: Silva, F.B., et al.
Publicado: (2014)

Therapeutic hypothermia after cardiac arrest increases the plasma level of B-type natriuretic peptide
por: Kashiwagi, Yusuke, et al.
Publicado: (2020)

Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides
por: Romano, Silvio, et al.
Publicado: (2010)

Plasma brain natriuretic peptide, platelet parameters, and cardiopulmonary function in chronic obstructive pulmonary disease
por: Guo, Hai-Jian, et al.
Publicado: (2021)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function
por: Buttgereit, Jens, et al.
Publicado: (2016)

Serum aminoterminal proctype natriuretic peptide in girls with idiopathic central precocious puberty during GNRHA treatment
por: Chen, Qiu-li, et al.
Publicado: (2013)

GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy
por: Shiraki, Aya, et al.
Publicado: (2019)

Plasma Amino-Terminal Propeptide of C-Type Natriuretic Peptide Concentration in Normal-Weight and Obese Children
por: Topçu, Seda, et al.
Publicado: (2017)

Effects of altered body fluid balance and high blood pressure on the plasma brain natriuretic peptide in rats.
por: Kim, S. W., et al.
Publicado: (1997)

Plasma levels of natriuretic peptides and development of chronic kidney disease
por: Ogawa, Noriyuki, et al.
Publicado: (2015)

Plasma brain natriuretic peptide levels are elevated in patients with cancer
por: Bando, Sachiko, et al.
Publicado: (2017)

Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
por: Hoffmann, U, et al.
Publicado: (2004)

The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis
por: Zhang, Pei, et al.
Publicado: (2019)

Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy
por: Pang, Aiming, et al.
Publicado: (2015)

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure
por: Greenberg, Barry, et al.
Publicado: (2019)

B‐type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis
por: Sato, Kimi, et al.
Publicado: (2018)

N‐terminal pro‐brain natriuretic peptide and short‐term mortality in acute aortic dissection: A meta‐analysis
por: Vrsalovic, Mislav, et al.
Publicado: (2020)

Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real‐world population
por: Zile, Michael R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_edaae16p84b64f53vkpg7hh6p6